Concurrent analysis of whole-genome DNA methylation and single-cell RNA sequencing data from COVID-19 patients and controls ...

MAIA Biotechnology receives USAN Council approval for “ateganosine” as nonproprietary name for anticancer agent THIO: Chicago Friday, March 21, 2025, 14:00 Hrs [IST] MAIA Biot ...

MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announces the publication of preclinical data for ...